Frequently Asked Questions
The market is segmented based on , By Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Oral Fluid, Others), Condition (Unconsciousness, Panic Attack, Chest Pain, Drug Allergies, Breathing Problem, Seizures, Organ Transplant, Pain Management, Others), Products and Services (Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Services), End-User (Workplace & Schools, Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, Pain Management Centers), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028
.
The North America Drug Screening Market size was valued at USD 0.00 USD Billion in 2021.
The North America Drug Screening Market is projected to grow at a CAGR of 8.75% during the forecast period of 2022 to 2028.
The major players operating in the market include Laboratory Corporation of America Holdings, Quest Diagnostics ,orporated, Thermo Fisher Scientific , MPD , Abbott, Drägerwerk AG & Co. KGaA, Alfa Scientific Designs , OMEGA LABORATORIES LTD, Premier Biotech , Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Shimadzu Corporation, Psychemedics Corporation, Bayer AG, AstraZeneca, Sanofi, Pfizer , GlaxoSmithKline plc, Merck & Co. , Johnson & Johnson Services .
